| 1 | 408321 | The treatment of enteric fever with mecillinam. | J Antimicrob Chemother | 1977 Jul |
1 |
| 2 | 1389936 | The pharmacokinetics of mecillinam and pivmecillinam in pregnant and non-pregnant women. | Br J Clin Pharmacol | 1992 Jun |
1 |
| 3 | 3061383 | In vitro activity of mecillinam and amoxicillin/clavulanic acid against strains of Escherichia coli producing TEM-1, Oxa-1 and chromosomal beta-lactamases. | Arzneimittelforschung | 1988 Jul |
7 |
| 4 | 6323378 | Pivmecillinam, co-trimoxazole and oral mecillinam in gastroenteritis due to Vibrio spp. | J Antimicrob Chemother | 1984 Feb |
2 |
| 5 | 10969046 | Comparative potency of mecillinam and other beta-lactam antibiotics against Escherichia coli strains producing different beta-lactamases. | J Antimicrob Chemother | 2000 Aug |
1 |
| 6 | 11051618 | Comparative potency of mecillinam and other beta-lactam antibiotics against Escherichia coli strains producing different beta-lactamases. | J Antimicrob Chemother | 2000 Sep |
1 |
| 7 | 11952728 | Mecillinam susceptibility as an indicator of beta-lactamase production in Staphylococcus aureus. | Clin Microbiol Infect | 2002 Feb |
3 |
| 8 | 17289762 | Function of penicillin-binding protein 2 in viability and morphology of Pseudomonas aeruginosa. | J Antimicrob Chemother | 2007 Mar |
1 |
| 9 | 24454943 | High rate of per oral mecillinam treatment failure in community-acquired urinary tract infections caused by ESBL-producing Escherichia coli. | PLoS One | 2014 |
7 |
| 10 | 28369441 | A combination of mecillinam and amoxicillin/clavulanate can restore susceptibility of high-level TEM-1-producing Escherichia coli to mecillinam. | J Antimicrob Chemother | 2017 Jul 1 |
3 |
| 11 | 30236958 | Synergistic and bactericidal activities of mecillinam, amoxicillin and clavulanic acid combinations against extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in 24-h time-kill experiments. | Int J Antimicrob Agents | 2019 Jan |
2 |
| 12 | 30917983 | Results from a Prospective <i>In Vitro</i> Study on the Mecillinam (Amdinocillin) Susceptibility of <i>Enterobacterales</i>. | Antimicrob Agents Chemother | 2019 Apr |
1 |
| 13 | 31243859 | Emerging clinical role of pivmecillinam in the treatment of urinary tract infections caused by Extended Spectrum βeta-lactamase (ESBL) producing Enterobacteriaceae. | Int J Clin Pract | 2019 Sep |
4 |
| 14 | 31573735 | Mutational change of CTX-M-15 to CTX-M-127 resulting in mecillinam resistant Escherichia coli during pivmecillinam treatment of a patient. | Microbiologyopen | 2019 Dec |
1 |
| 15 | 31596663 | Evaluation of Antimicrobial Effects of a New Polymyxin Molecule (SPR741) When Tested in Combination with a Series of β-Lactam Agents Against a Challenge Set of Gram-Negative Pathogens. | Microb Drug Resist | 2020 Apr |
1 |
| 16 | 32120467 | Prevalence, antibiotic sensitivity pattern and genetic analysis of extended spectrum beta lactamase producing Escherichia coli and Klebsiella spp among patients with community acquired urinary tract infection in Galle district, Sri Lanka | Ceylon Med J | 2019 Dec 31 |
2 |
| 17 | 32868328 | <i>In Vivo</i> Evolution of CTX-M-215, a Novel Narrow-Spectrum β-Lactamase in an Escherichia coli Clinical Isolate Conferring Resistance to Mecillinam. | Antimicrob Agents Chemother | 2020 Oct 20 |
1 |